#Bioethics

Desperate for relief from pain and promising a chance to turn back the clock, affluent medical tourists are now spending up to $60,000 for unproven stem-cell injections in offshore clinics—a trend that experts warn is driven by hype, hope, and significant regulatory gaps. High-end patients from Silicon Valley and beyond are boarding flights to destinations like the Bahamas, Panama, and Costa Rica, seeking these exclusive therapies that remain illegal or tightly restricted in the United States due to safety concerns and a lack of clinical validation. This new “luxury medical tourism” is quickly becoming a global industry, raising major questions about risk, reward, and responsibility for Thailand, one of the world’s leading medical tourism hubs.

A significant milestone in brain-computer interface (BCI) development has arrived as US health regulators granted approval to a key component of a brain implant developed by Precision Neuroscience, a direct competitor to Elon Musk’s Neuralink. This green light from the Food and Drug Administration (FDA) sets the stage for new advances in neural implants—offering hope not just to patients with paralysis or neurological disorders, but also sparking debates about the ethical, medical, and social impacts of such technology worldwide, including here in Thailand.